Expert second opinions for mitral valve prolapse. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Mitral Valve Prolapse (MVP) affects 2-3% of the population. If you are facing a decision about mitral valve prolapse, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Mitral valve prolapse (MVP) affects 2-3% of the population. While most cases are benign, a subset develops significant mitral regurgitation requiring surgical intervention. The hallmark is billowing of one or both valve leaflets into the left atrium during systole.
The spectrum of MVP ranges from benign to complex Barlow's disease requiring extensive valve reconstruction. Determining when MVP has progressed to the point of requiring surgery — and whether repair is feasible — requires specialized expertise. At expert reference centers, repair rates for complex MVP exceed 95%.
Surgery for mitral valve prolapse depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. The spectrum of MVP ranges from benign to complex Barlow's disease requiring extensive valve reconstruction. Determining when MVP has progressed to the point of requiring surgery — and whether repair is feasible — requires specialized expertise. At expert reference centers, repair rates for complex MVP exceed 95%.
Operative mortality for mitral valve prolapse-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for mitral valve prolapse depends on anatomy, comorbidities, age, and personal goals. Surveillance vs surgical intervention timing. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.